Literature DB >> 26780230

A Meta-analysis on the Effect of Ulinastatin on Serum Levels of C-Reactive Protein, Interleukin 6, and Tumor Necrosis Factor Alpha in Asian Patients with Acute Pancreatitis.

Chunze Zhang1, Yijia Wang2, Wenzheng Fu1, Weihua Zhang1, Tao Wang1, Hai Qin1.   

Abstract

OBJECTIVES: We aimed to investigate the influence of ulinastatin (UTI) on the serum levels of C-reactive protein (CRP), interleukin 6 (IL-6), and tumor necrosis factor alpha (TNF-α) in Asian patients with acute pancreatitis (AP) by performance of a meta-analysis.
METHODS: Two investigators independently searched 11 databases, including PUBMED, EBSCO, Ovid, SpringerLink, Wiley, Web of Science, Cochrane Library, Wanfang database, China National Knowledge Infrastructure (CNKI), Chinese Journal Full-text Database, and China Biomedicine Database. The full-text articles were screened and the data were extracted using a standardized data extraction form. All statistical analyses were conducted with Stata software, version 12.0 (Stata Corporation, College Station, TX).
RESULTS: A total of 94 studies were initially retrieved, and 10 studies containing 424 Asian patients with AP were ultimately enrolled in this meta-analysis. The results revealed that the serum levels of CRP, IL-6, and TNF-α in Asian AP patients significantly decreased after UTI therapy (CRP: standardized mean difference [SMD] = 3.26, 95% confidence interval [CI] = 1.69-4.83, p < 0.001; IL-6: SMD = 5.92, 95% CI = 2.09-9.75, p = 0.002; TNF-α: SMD = 4.07, 95% CI = 0.79-7.35, p = 0.015).
CONCLUSION: The results of this meta-analysis suggest that UTI can effectively depress the serum levels of CRP, IL-6, and TNF-α in Asian patients with AP, and thereby inhibit inflammation.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26780230     DOI: 10.1089/gtmb.2015.0192

Source DB:  PubMed          Journal:  Genet Test Mol Biomarkers        ISSN: 1945-0257


  7 in total

1.  Predicative values of C-reactive protein for the therapeutic effects of ulinastatin combined with somatostatin in severe acute pancreatitis and for the severity of gastrointestinal failure.

Authors:  Yinjia Wang; Li Li
Journal:  Exp Ther Med       Date:  2018-08-07       Impact factor: 2.447

2.  Ulinastatin protects the lungs of COPD rats through the HMGB1/TLR4 signaling pathway.

Authors:  Wei Liu; Zhiguang Liu; Weidong Zhang; Shaoxi Cai
Journal:  Oncol Lett       Date:  2018-07-11       Impact factor: 2.967

3.  Ulinastatin plus biapenem for severe pneumonia in the elderly and its influence on pulmonary function and inflammatory cytokines.

Authors:  Rui Zhang; Jitao Ma; Pengxiao Zheng; Ruirui Zheng; Xu Meng; Yinjia Wang
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

4.  Ulinastatin ameliorates tissue damage of severe acute pancreatitis through modulating regulatory T cells.

Authors:  Yu Pan; Haizong Fang; Fengchun Lu; Minggui Pan; Fei Chen; Ping Xiong; Yi Yao; Heguang Huang
Journal:  J Inflamm (Lond)       Date:  2017-03-20       Impact factor: 4.981

Review 5.  Cancer vs. SARS-CoV-2 induced inflammation, overlapping functions, and pharmacological targeting.

Authors:  Sreedhar Amere Subbarao
Journal:  Inflammopharmacology       Date:  2021-03-15       Impact factor: 5.093

6.  Cryptdin-2 predicts intestinal injury during heatstroke in mice.

Authors:  Jingjing Ji; Zhengtao Gu; Hui Li; Lei Su; Zhifeng Liu
Journal:  Int J Mol Med       Date:  2017-11-01       Impact factor: 4.101

7.  Qingyi decoction attenuates severe acute pancreatitis in rats via inhibition of inflammation and protection of the intestinal barrier.

Authors:  Song Su; Tiancheng Liang; Xiang Zhou; Kai He; Bo Li; Xianming Xia
Journal:  J Int Med Res       Date:  2019-01-30       Impact factor: 1.671

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.